The vitronectin receptor Alpha-v beta-3, contrary to ICAM-1, is not modulated by interferon-gamma and tumour necrosis factor-alpha on melanoma cell lines

Acta Dermato-Venereologica

Volumn 76, Issue 4, 1996, Pages 269-273

  Boccaletti, V ^a   Temponi, M ^a   Wang, Z ^b   Manganoni, A M ^a   Marcelli, M ^a   Maio, M ^c   Ferrone, S ^b   De Panfilis, G ^a  

^a Spedali Civili ^*  (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Adhesion molecules; Cytotoxicity; Metastasis

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; VITRONECTIN RECEPTOR;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL;

CYTOTOXICITY, IMMUNOLOGIC; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-2; MELANOMA; RADIOIMMUNODETECTION; RECEPTORS, VITRONECTIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030018590     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hynes RO. Integrins: a family of cell-surface receptors. Cell 1987; 48: 549-554.
2. Juliano RL. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochem Biophys Acta 1987; 907: 261-278.
3. Albelda SM, Buck CL. Integrins and other cell adhesion molecules. FASEB 1990; 4: 2868-2880.
4. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-842.
5. Ng-Sikorski J, Andersson R, Patarroyo M. Calcium signaling capacity of the CD11b/CD18 integrin on human neutrophils. Exp Cell Res 1991; 195: 504-508.
6. Leptin M, Bogaert T, Lehmann R, Wilcox M. The function of PS integrin during drosophila embryogenesis. Cell 1989; 56: 401-408.
7. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987; 38: 175-194.
8. Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA. Involvement of integrin alpha v gene expression in human melanoma tumorigenicity. J Clin Invest 1992; 89: 2018-2022.
9. Charo IF, Nannizzi L, Smith JW, Cheresh DA. The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 1990; 111: 2795-2800.
10. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an arg-gly-asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrandt factor. J Biol Chem 1987; 262: 17703-17711.
11. Conforti G, Zanetti A, Colella S, et al. Interaction of fibronectin with cultured human endothelial cells: characterization of the specific receptor. Blood 1989; 73: 1576-1585.
12. Cheng Y-F, Kramer RH. Human microvascular endothelial cells express integrin-related complexes that mediate adhesion to the extracellular matrix. J Cell Physiol 1989; 139: 275-286.
13. Albelda SM, Daise M, Levine EM, Buck CA. Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. J Clin Invest 1989; 83: 1992-2002.
14. Cheresh DA, Smith JW, Cooper HM, Quaranta V. A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell 1989; 57: 59-69.
15. Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin: adhesion mechanisms for transformed glial cells. J Clin Invest 1991; 83: 1924-1932.
16. Cheresh DA. Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells. Cancer Metas Rev 1991; 10: 3-10.
17. Clark WH, Elder DE, Guerry D 4th, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147-1165.
18. Barsky SH, Rao CN, Williams JE, Liotta LA. Laminin molecular domain which alters metastasis in a murine model. J Clin Invest 1984; 74: 843-848.
19. Fidler IJ. Critical factors in the biology of human cancer metastasis. Claws memorial award lecture. Cancer Res 1990; 50: 6130-6138.
20. Seftor REB, Seftor EA, Gehlsen KR, et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 1992; 89: 1557-1561.
21. Defilippi P, Truffa G, Stefanuto G, et al. Tumor necrosis factor-alpha and interferon-gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells. J Biol Chem 1991; 266: 7638-7645.
22. Pandolfi F, Trentin L, Lenora A, et al. Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes. Cancer 1992; 69: 1165-1173.
23. Temponi M, Romano C, D'Urso CM, et al. Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines. Semin Oncol 1988; 15: 595-607.
24. 2m gene expression. J Clin Invest 1991; 87: 284-292.
25. Fogh J, Bean MA, Bruggen J, et al. Comparison of human tumor cell line before and after growth in the nude mouse. In: Fogh J, Giovanella B, eds. The nude mouse in experimental and clinical research. New York: Academic Press, 1978: 215-234.
26. Schadendorf D, Yamaguchi H, Old LJ, Srivastava PK. A novel heteromorphic human cell surface alloantigen. gp 60, defined by a human monoclonal antibody. J Immunol 1989; 142: 1621-1628.
27. Matsui M, Temponi M, Ferrone S. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune Interferon. J Immunol 1987; 139: 2088-2094.
28. Temponi M, Kageshita T, Perosa I, et al. Purification of murine IgG monoclonal antibodies by precipitation with caprilic acid: comparison with other methods of purification. Hybridoma 1989; 8: 85-95.
29. Fraker PJ, Speck JC jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide. 1,3,4,6-tetrachloro-3a,6a-diphenyl-glycoluryl. Biochem Biophys Res Commun 1978; 80: 849-857.
30. Lindmo T, Boven E, Cuttitta F, et al. Determination of the immunoreactive fraction of radiolabelled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984; 72: 77-89.
31. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by IFN-gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med 1988; 167: 1323-1340.
32. Norris DR. Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol 1990; 95: 111S-120S.
33. Kupper T. Immune and inflammatory processes in cutaneous tissues. J Clin Invest 1991; 86: 1783-1789.
34. Balkwill FR. In: Taylor-Papadimitriou J, ed. Interferons, their impact in biology and medicine. Oxford: Medical Publication, 1985: 61-80.
35. Dinarello CA, Mier JW. Lymphokines. New Engl J Med 1987; 317: 940-945.
36. Sone S, Utsugi TK, Ogura T. Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity. J Natl Cancer Inst 1988; 80: 425-431.
37. Talmadge JE, Phillips H, Schneider M, et al. Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res 1988; 48: 544-550.
38. Johnson PJ, Stade BG, Holzmann B, et al. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989; 86: 641-644.
39. Natali PG, Nicotra MR, Cavaliere R, et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990; 50: 1271-1278.
40. Becker JC, Dummer R, Hartmann AA, et al. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. J Immunol 1991; 147: 4398-4401.
41. Manganoni AM, Bugari G, Poiesi C, et al. Identification of free circulating intercellular adhesion molecule-1 in patients with metastatic melanoma. J Invest Dermatol 1992; 98: 541.
42. Marshall JF, Nesbitt SA, Helfrich MH, et al. Integrin expression in human melanoma cell lines: heterogeneity in vitronectin receptor composition and function. Int J Cancer 1991; 49: 924-931.